DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Warby - 1 Goldman Sachs - 1 Brooke Roach - 1 Warby Parker - 1 Roach - 1 Yuna Rapoport - 1 — you’ll - 1 ” - 1
Top related locs:
Manhattan generics Norwich
Top related orgs:
NBC - 1 Eyecare - 1 Burberry - 1 Carrera - 1 Nike - 1 Eyebuydirect - 1 Armani Exchange - 1 ” - 1

Search resuls for: "Eyecare"


5 mentions found


☆ Goldman Sachs upgrades Warby Parker to buy, cites strong margin growth as catalyst
  + stars: | 2024-10-21 | by ( Lisa Kailai Han | ) www.cnbc.com   time to read: +2 min
Analyst Brooke Roach noted that while the stock's valuation "remains somewhat elevated," Warby Parker's strong fundamentals and margin growth outlook justifies outperformance from here. Warby Parker trades at a forward price-to-earnings multiple of 69, well above the S & P 500's 24.6 ratio. Warby Parker also has a track record of maximizing its labor operations and first-year store profitability. Analysts are generally bullish on Warby Parker, which is up 17% for the year. Of the 15 covering the stock, eight have buy or strong buy ratings, LSEG data shows.
Persons: Warby, Goldman Sachs, Brooke Roach, Warby Parker, Roach
☆ Where to buy glasses online, according to editors and experts
  + stars: | 2024-09-19 | by ( Bethany Heitman | Bethany Heitman Is A Contributing Editor At Nbc Select. | ) www.nbcnews.com   time to read: +11 min
SKIP AHEAD How we picked the best online eyeglasses retailers | Where to buy glasses online | Why trust NBC Select? To help guide you through buying glasses online we asked experts what to consider before shopping, and we rounded up some of the best online retailers for eyeglasses. Where to buy glasses onlineWe rounded up some of the most popular online eyeglasses retailers to make your online search for glasses easier. Those nervous about shopping online may find comfort in buying glasses from a known name in the glasses world. For this story, she interviewed two experts on where to buy glasses online.
Persons: Yuna Rapoport, — you’ll, ”, Rapoport, “, —, Thierry Hufnagel, Gucci, Kate Spade, Marc Jacobs, Ban, you’ve, Tom Ford, Versace, Prada, Persol, you’ll, Bethany Heitman, TikTok Organizations: NBC, Eyecare, Burberry, Carrera, Nike, Eyebuydirect, Armani Exchange, ”, Facebook, Twitter Locations: Manhattan
☆ Bausch Health investors are left in a holding pattern as 2 major overhangs remain unresolved
  + stars: | 2024-05-02 | by ( Jim Cramer | ) www.cnbc.com   time to read: +5 min
Bausch Health Companies on Tuesday morning reported first-quarter top- and bottom-line misses — putting embattled shares under pressure. BHC YTD mountain Bausch Health YTD Bottom line Along with quarterly results, Bausch Health reaffirmed forward guidance. While not necessarily expected to see a massive increase in adoption in the future like Lilly's GLP-1s, Xifaxan currently accounts for 41% of Bausch Health sales, excluding B+L. Breaking that down: $4.7 billion to $4.85 billion are attributable to Bausch Health (implying 2% to 5% organic growth), with $4.6 billion to $4.7 billion attributable to Bausch + Lomb. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade.
Persons: Bausch, Eli Lilly, It's, Xifaxan, Jim Cramer's, Jim Cramer, Jim, Rafael Henrique Organizations: Health, Bausch Health, Norwich Pharmaceuticals, Amneal Pharmaceuticals, Food and Drug Administration, Management, CNBC Locations: generics, Norwich
☆ Here are Wednesday's biggest analyst calls: Apple, Tesla, Walmart, Chevron, Lumentum, Rivian & more
  + stars: | 2023-05-10 | by ( Michael Bloom | ) www.cnbc.com   time to read: +7 min
Barclays initiates 10X Genomics as overweight Barclays said in its initiation of the gene sequencing biotech company that it has margin expansion opportunities for 10X. Barclays reiterates Apple as equal weight Barclays said in its analysis of Apple TV+ that "incremental content spend could take some cash away from buybacks." Goldman Sachs reiterates Chevron as neutral Goldman said it's waiting for an "upstream inflection" before getting positive on Chevron shares. Bank of America reiterates Virgin Galactic as underperform Bank of America said it still sees too much uncertainty for the spaceflight company. Bank of America reiterates Rivian as buy Bank of America saidit's standing by shares of the electric vehicle company after its earnings report on Tuesday.
☆ Bausch Health's stock soars on solid quarterly results, but we have concerns about the recovery
  + stars: | 2023-02-23 | by ( Zev Fima | ) www.cnbc.com   time to read: +4 min
Bottom line The Canadian specialty pharmaceuticals company reported solid results for the fourth quarter, along with favorable forward guidance. Bausch management on Thursday did not offer additional information, other than to reiterate its confidence in the strength of the company's patents. Bausch Health previously started the separation process via an initial public offering of Bausch + Lomb in May 2022. Results at the diversified products division — which includes neurology pharmaceutical products, generics and dentistry products — were hampered by generic competition. Notably, as Bausch Health owns most of Bausch + Lomb, the latter's financials still appear on Thursday's results.
0 next >>
Total: 5